FDA inspection
Ivax Pharmaceuticals Inc: FDA inspection ending Nov 17, 2003
FDA inspection 301837 · Voluntary Action Indicated (VAI) · Northvale, NJ
Key facts
| Inspection ID | 301837 |
|---|---|
| Firm | Ivax Pharmaceuticals Inc |
| FEI number | 2219541 |
| Address | 140 Legrand Ave |
| City | Northvale |
| State | NJ |
| ZIP | 07647-2403 |
| Fiscal year | 2004 |
| Inspection end date | Nov 17, 2003 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data